
Pancreatin Tablets
Form: Tablets
Strength: 10,000, 25,000, 40,000, 50,000, 80,000 USP units.
Reference Brands: Creon(US)
Category: Gastrointestinal Drugs
Pancreatin tablets, containing essential digestive enzymes, are approved in the US by the FDA and in the EU via EMA for pancreatic enzyme replacement therapy in pancreatitis and pancreatic insufficiency. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial and quality data for timely approval, while the EMA ensures regional safety, efficacy, and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe use, and broad availability of pancreatin tablets, helping improve digestion and nutritional health worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Sucralfate tablet
Strength: 1 g
Form: Tablets
Reference Brands: Carafate(US)
View Details Get EnquirySimethicone tablet
Strength: 40 mg
Form: Tablets
Reference Brands: Mylicon(US)
View Details Get EnquiryUrsodeoxycholic Acid capsule
Strength: 150 mg, 300 mg
Form: Capsules
Reference Brands: Actigall(US), rsofalk, Ursocaps, Ursode(EU)
View Details Get EnquiryL-Ornithine L-Aspartate powder
Strength: 5 g, 10 g, or 15 g
Form: Powder for Reconstitution for oral use
Reference Brands: Liv.52, HepaMerz(EU)
View Details Get Enquiry